Product image of Pralia Subcutaneous (Denosumab) 60mg PFS supplied by GNH India

Pralia Subcutaneous

Active Ingredient:
Denosumab
Form:
PFS
Brand:
Pralia
Origin:
Japan

Pralia Subcutaneous (Denosumab PFS) 60mg

Pralia Subcutaneous (Denosumab 60mg) is a prescription injection used to treat bone loss and reduce fracture risk. This prefilled syringe supports convenient self-administration at home under medical guidance. Store between 2-8°C to maintain potency. Always follow healthcare provider instructions when using Pralia.

Strength

60mg

Pack Size

1s

Storage

2-8°

Manufacturer / TM Owner

Daiichi Sankyo Company, Limited.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Pralia Subcutaneous (Denosumab 60mg) is commonly prescribed to help manage bone density loss in adults. It supports treatment for osteoporosis and reduces the risk of fractures in postmenopausal women and men with low bone mass. This medication works by slowing bone breakdown to strengthen skeletal structure over time.

Side Effects

  • Users of Pralia Subcutaneous may notice improved bone strength and reduced fracture risk with consistent use. Some individuals report temporary redness or swelling at the injection site, which typically resolves quickly. Most effects are gradual and best assessed through regular medical monitoring and follow-up tests.

Precautions & Warnings

  • Keep Pralia Subcutaneous refrigerated between 2-8°C and protect it from light. Do not freeze or shake vigorously. Before use, inspect the solution for particles or discoloration; discard if any changes are observed. Always follow the handling and disposal instructions provided by your healthcare professional.

Avoid Interactions

  • Pralia Subcutaneous may interact with other medications that affect bone metabolism, such as corticosteroids or certain cancer treatments. Avoid combining it with other injectable osteoporosis therapies unless directed by a doctor. Inform your healthcare provider about all medications and supplements you are taking to minimize potential interactions.

References

Frequently Asked Questions

Pralia Subcutaneous (Denosumab 60mg) is used to treat osteoporosis and reduce fracture risk in adults with low bone density.

Store Pralia Subcutaneous in the refrigerator between 2-8°C and protect it from light. Do not freeze.

Pralia Subcutaneous is designed for self-administration at home, but only under the guidance of a healthcare provider.

Contact your healthcare provider if you miss a dose for guidance on resuming treatment safely.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Denosumab

Xgeva 120mg

Xgeva 120mg

120mg/1.7ml (70mg/ml) Vials
Prolia 60mg

Prolia 60mg

60mg/ml x 1ml PFS
Denosurel

Denosurel

120mg/1.7ml Vials
Prolia 60mg

Prolia 60mg

60mg/ml x 1ml PFS

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT